Varian Medical Systems Company Profile (NYSE:VAR)

About Varian Medical Systems (NYSE:VAR)

Varian Medical Systems logoVarian Medical Systems, Inc. is a manufacturer of medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy and brachytherapy medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy and brachytherapy. The Company also has Varian Particle Therapy (VPT) and the operations of the Ginzton Technology Center (GTC). Its VPT business develops, designs, manufactures, sells and services products and systems for delivering proton therapy, another form of external beam radiotherapy using proton beams for the treatment of cancer. Its ProBeam system is capable of delivering intensity modulated proton therapy (IMPT) using pencil beam scanning technology. Its ProBeam Compact is a single room proton therapy product.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Advanced Medical Equipment & Technology
  • Sub-Industry: Health Care Equipment
  • Symbol: NYSE:VAR
  • CUSIP: 92220P10
  • Web:
  • Market Cap: $9.69 billion
  • Outstanding Shares: 91,800,000
Average Prices:
  • 50 Day Moving Avg: $104.02
  • 200 Day Moving Avg: $99.70
  • 52 Week Range: $75.20 - $107.87
  • Trailing P/E Ratio: 34.36
  • Foreward P/E Ratio: 23.78
  • P/E Growth: 2.62
Sales & Book Value:
  • Annual Revenue: $3.27 billion
  • Price / Sales: 2.96
  • Book Value: $15.16 per share
  • Price / Book: 6.97
  • EBITDA: $643 million
  • Net Margins: 9.50%
  • Return on Equity: 24.70%
  • Return on Assets: 11.12%
  • Debt-to-Equity Ratio: 0.18%
  • Current Ratio: 1.62%
  • Quick Ratio: 1.26%
  • Average Volume: 733,083 shs.
  • Beta: 0.56
  • Short Ratio: 7.65

Frequently Asked Questions for Varian Medical Systems (NYSE:VAR)

What is Varian Medical Systems' stock symbol?

Varian Medical Systems trades on the New York Stock Exchange (NYSE) under the ticker symbol "VAR."

How were Varian Medical Systems' earnings last quarter?

Varian Medical Systems, Inc. (NYSE:VAR) posted its earnings results on Wednesday, July, 26th. The company reported $1.04 earnings per share for the quarter, beating the Zacks' consensus estimate of $0.95 by $0.09. The business earned $662.40 million during the quarter, compared to analyst estimates of $663.86 million. Varian Medical Systems had a return on equity of 24.70% and a net margin of 9.50%. The company's quarterly revenue was up 3.0% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $1.00 EPS. View Varian Medical Systems' Earnings History.

When will Varian Medical Systems make its next earnings announcement?

Varian Medical Systems is scheduled to release their next quarterly earnings announcement on Wednesday, October, 25th 2017. View Earnings Estimates for Varian Medical Systems.

What guidance has Varian Medical Systems issued on next quarter's earnings?

Varian Medical Systems updated its fourth quarter earnings guidance on Wednesday, July, 26th. The company provided earnings per share guidance of $1.15-$1.23 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $1.18.

Where is Varian Medical Systems' stock going? Where will Varian Medical Systems' stock price be in 2017?

10 analysts have issued 1 year target prices for Varian Medical Systems' shares. Their predictions range from $81.50 to $106.00. On average, they expect Varian Medical Systems' share price to reach $94.94 in the next year. View Analyst Ratings for Varian Medical Systems.

What are analysts saying about Varian Medical Systems stock?

Here are some recent quotes from research analysts about Varian Medical Systems stock:

  • 1. According to Zacks Investment Research, "Varian Medical's oncology and Proton therapy business growth prospects remain impressive. The company is addressing both the tier 1 and mid-tier markets through its Edge, Truebeam and VitalBeam, Halcyon products. Varian has been winning contracts, not only in the Americas but also in the emerging international markets, which is a huge positive. We believe China and Africa present significant top-line growth opportunity in the near term. The company is opening up new offices in Africa and the Middle East, which shows that it is aware of the growth opportunities in the region. Varian Medical posted an impressive second quarter of fiscal 2017, beating the Zacks Consensus Estimate on both the counts. The company’s upbeat guidance for the coming quarters is a positive. Share price movement in the past three months has been encouraging, trading above the broader industry." (7/13/2017)
  • 2. Jefferies Group LLC analysts commented, "We hosted VAR CEO and CFO for a lunch. Key takeaways: 1) VREX spin process was all inclusive; 2) F17 RemainCo outlook calls for HSD EPS growth; 3) RadOnc outlook stable on multiple fronts near and long-term; 3) next-gen linac expected in 2H17; 5) aim is to double Software in 5-years; 6) proton stable postCTCL with glimmers of light in tunnel; and 7) at least $1.0bn in debt capacity for M&A. We are publishing revised stand-alone estimates and PT of $88." (2/8/2017)

Who are some of Varian Medical Systems' key competitors?

Who are Varian Medical Systems' key executives?

Varian Medical Systems' management team includes the folowing people:

  • R. Andrew Eckert, Independent Chairman of the Board
  • Dow R. Wilson, President, Chief Executive Officer
  • Timothy E. Guertin, Vice Chairman of the Board
  • Elisha W. Finney, Chief Financial Officer, Executive Vice President - Finance
  • Gary E. Bischoping Jr., Chief Financial Officer
  • Kolleen T. Kennedy, Executive Vice President and President - Oncology Systems
  • John W. Kuo, Senior Vice President, General Counsel, Corporate Secretary
  • Rafael Torres, Senior Vice President - Business Development and Strategy
  • Jose Baselga M.D., Ph.D., Director
  • Jean-Luc Butel, Director

How do I buy Varian Medical Systems stock?

Shares of Varian Medical Systems can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Varian Medical Systems' stock price today?

One share of Varian Medical Systems stock can currently be purchased for approximately $105.60.

MarketBeat Community Rating for Varian Medical Systems (NYSE VAR)
Community Ranking:  2.6 out of 5 (star star)
Outperform Votes:  336 (Vote Outperform)
Underperform Votes:  302 (Vote Underperform)
Total Votes:  638
MarketBeat's community ratings are surveys of what our community members think about Varian Medical Systems and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for Varian Medical Systems (NYSE:VAR) (How are Consensus Ratings Calculated?)
Ratings Breakdown: 2 Sell Ratings, 6 Hold Ratings, 2 Buy Ratings
Consensus Rating:Hold (Score: 2.00)
Consensus Price Target: $94.94 (10.10% downside)
Consensus Price Target History for Varian Medical Systems (NYSE:VAR)
Price Target History for Varian Medical Systems (NYSE:VAR)
Analysts' Ratings History for Varian Medical Systems (NYSE:VAR)
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
9/7/2017BTIG ResearchDowngradeBuy -> NeutralMediumView Rating Details
9/1/2017Royal Bank Of CanadaReiterated RatingHold$100.00N/AView Rating Details
8/28/2017Robert W. BairdReiterated RatingHold$99.00LowView Rating Details
5/17/2017AegisReiterated RatingHold$91.00LowView Rating Details
5/16/2017Goldman Sachs Group, Inc. (The)Initiated CoverageNeutral -> Neutral$92.00LowView Rating Details
5/15/2017Citigroup Inc.UpgradeNeutral -> BuyLowView Rating Details
5/11/2017Jefferies Group LLCReiterated RatingBuyLowView Rating Details
4/27/2017Barrington ResearchDowngradeOutperform -> Market PerformHighView Rating Details
4/24/2017Off Wall StreetInitiated CoverageSellLowView Rating Details
1/26/2017Evercore ISIDowngradeHold -> Sell$81.50N/AView Rating Details
7/28/2016Morgan StanleyBoost Price TargetUnderweight$80.00 -> $86.00N/AView Rating Details
7/28/2016Brean CapitalBoost Price TargetBuy$87.00 -> $90.00N/AView Rating Details
10/20/2015J P Morgan Chase & CoReiterated RatingNeutral$95.00 -> $75.00N/AView Rating Details
(Data available from 10/20/2015 forward)


Earnings History for Varian Medical Systems (NYSE:VAR)
Earnings by Quarter for Varian Medical Systems (NYSE:VAR)
Earnings History by Quarter for Varian Medical Systems (NYSE VAR)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
10/24/2017$1.19N/AView Earnings Details
7/26/2017Q3 2017$0.95$1.04$663.86 million$662.40 millionViewN/AView Earnings Details
4/26/2017Q2 2017$0.88$0.89$639.26 million$655.00 millionViewN/AView Earnings Details
10/26/2016Q4112$1.34$1.38$880.29 million$912.00 millionViewListenView Earnings Details
7/27/2016Q316$1.17$1.22$779.90 million$789.40 millionViewListenView Earnings Details
4/27/2016Q216$1.08$1.09$769.56 million$758.80 millionViewListenView Earnings Details
1/27/2016Q116$0.94$0.99$748.01 million$757.00 millionViewListenView Earnings Details
10/28/2015Q4$1.10$1.04$813.18 million$817.80 millionViewListenView Earnings Details
7/29/2015Q3$1.10$1.13$810.41 million$784.00 millionViewListenView Earnings Details
4/29/2015Q215$1.00$1.05$799.66 million$759.40 millionViewN/AView Earnings Details
1/28/2015Q115$0.87$0.99$720.83 million$737.90 millionViewN/AView Earnings Details
10/22/2014Q415$1.21$1.02$837.86 million$812.10 millionViewListenView Earnings Details
7/23/2014Q314$1.09$1.08$767.52 million$747.70 millionViewN/AView Earnings Details
4/23/2014Q4112$1.03$1.04$772.84 million$779.00 millionViewN/AView Earnings Details
1/22/2014Q3112$0.90$0.91$718.23 million$712.00 millionViewN/AView Earnings Details
10/23/2013Q3112$1.12$1.08$779.02 million$770.00 millionViewN/AView Earnings Details
7/24/2013Q3 2013$1.01$1.03$749.01 million$726.20 millionViewN/AView Earnings Details
4/24/2013Q2 2013$1.02$1.04$758.02 million$768.40 millionViewN/AView Earnings Details
1/23/2013Q1 2013$0.87$0.86$676.15 million$678.40 millionViewN/AView Earnings Details
10/25/2012$1.03$1.08ViewN/AView Earnings Details
7/25/2012$0.94$0.96ViewN/AView Earnings Details
4/25/2012$0.96$0.96ViewN/AView Earnings Details
1/25/2012$0.75$0.79ViewN/AView Earnings Details
10/27/2011$0.97$0.95ViewN/AView Earnings Details
7/27/2011$0.83$0.83ViewN/AView Earnings Details
4/27/2011$0.85$0.86ViewN/AView Earnings Details
1/26/2011$0.73$0.80ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for Varian Medical Systems (NYSE:VAR)
2017 EPS Consensus Estimate: $4.18
2018 EPS Consensus Estimate: $4.43
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20172$1.04$1.06$1.05
Q2 20172$0.91$1.08$1.00
Q3 20172$0.94$0.95$0.95
Q4 20172$1.17$1.20$1.19
Q1 20182$0.93$1.07$1.00
Q2 20182$1.02$1.03$1.03
Q3 20182$1.07$1.14$1.11
Q4 20182$1.26$1.33$1.30
(Data provided by Zacks Investment Research)


Dividend History for Varian Medical Systems (NYSE:VAR)
No dividend announcements for this company have been tracked by

Insider Trades

Insider Trading and Institutional Ownership History for Varian Medical Systems (NYSE:VAR)
Insider Ownership Percentage: 0.91%
Institutional Ownership Percentage: 99.24%
Insider Trades by Quarter for Varian Medical Systems (NYSE:VAR)
Institutional Ownership by Quarter for Varian Medical Systems (NYSE:VAR)
Insider Trades by Quarter for Varian Medical Systems (NYSE:VAR)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
10/18/2017Kolleen T KennedyEVPSell931$105.00$97,755.00View SEC Filing  
10/12/2017Kolleen T KennedyEVPSell1,088$101.55$110,486.40View SEC Filing  
10/6/2017Dow R WilsonInsiderSell15,059$102.40$1,542,041.60View SEC Filing  
10/6/2017R Andrew EckertDirectorSell5,651$102.39$578,605.89View SEC Filing  
9/13/2017Kolleen T KennedyEVPSell933$107.29$100,101.57View SEC Filing  
9/12/2017Kolleen T KennedyEVPSell1,088$107.33$116,775.04View SEC Filing  
9/7/2017Dow R WilsonInsiderSell15,059$105.41$1,587,369.19View SEC Filing  
8/31/2017Kolleen T KennedyEVPSell931$105.00$97,755.00View SEC Filing  
8/14/2017Kolleen T KennedyEVPSell1,088$97.91$106,526.08View SEC Filing  
8/7/2017Dow R WilsonInsiderSell15,059$96.48$1,452,892.32View SEC Filing  
7/13/2017John W KuoSVPSell1,597$104.43$166,774.71View SEC Filing  
7/13/2017Kolleen T KennedyEVPSell2,021$104.73$211,659.33View SEC Filing  
7/12/2017John W KuoSVPSell863$104.48$90,166.24View SEC Filing  
7/12/2017Kolleen T KennedyEVPSell1,088$104.49$113,685.12View SEC Filing  
7/10/2017Dow R WilsonInsiderSell15,060$103.37$1,556,752.20View SEC Filing  
6/20/2017Kolleen T KennedyEVPSell26,092$105.00$2,739,660.00View SEC Filing  
6/13/2017John W KuoSVPSell734$101.91$74,801.94View SEC Filing  
6/12/2017John W KuoSVPSell863$101.25$87,378.75View SEC Filing  
6/12/2017Kolleen T KennedyEVPSell1,087$101.20$110,004.40View SEC Filing  
6/9/2017Timothy E GuertinDirectorSell16,000$103.22$1,651,520.00View SEC Filing  
6/8/2017Mark R LaretDirectorSell1,428$103.47$147,755.16View SEC Filing  
6/1/2017Kolleen T KennedyEVPSell56,573$99.76$5,643,722.48View SEC Filing  
5/31/2017John W KuoSVPSell19,819$99.67$1,975,359.73View SEC Filing  
5/12/2017John W KuoSVPSell862$96.39$83,088.18View SEC Filing  
5/2/2017Susan L BostromDirectorSell3,589$91.08$326,886.12View SEC Filing  
4/12/2017John W KuoSVPSell864$89.74$77,535.36View SEC Filing  
3/17/2017John W KuoSVPSell3,876$91.75$355,623.00View SEC Filing  
3/13/2017John W KuoSVPSell862$87.89$75,761.18View SEC Filing  
3/1/2017John W KuoSVPSell10,353$84.81$878,037.93View SEC Filing  
1/5/2017Dow R WilsonInsiderSell13,334$88.74$1,183,259.16View SEC Filing  
12/8/2016John W KuoSVPSell1,267$90.33$114,448.11View SEC Filing  
12/5/2016Dow R WilsonInsiderSell10,000$90.03$900,300.00View SEC Filing  
11/7/2016Dow R WilsonInsiderSell10,000$90.59$905,900.00View SEC Filing  
10/31/2016Timothy E GuertinDirectorSell4,000$90.32$361,280.00View SEC Filing  
10/20/2016John W KuoSVPSell21,266$103.70$2,205,284.20View SEC Filing  
10/5/2016Dow R WilsonInsiderSell10,000$99.44$994,400.00View SEC Filing  
10/3/2016Elisha W FinneyCFOSell4,668$98.87$461,525.16View SEC Filing  
9/15/2016John W KuoSVPSell4,073$95.47$388,849.31View SEC Filing  
9/7/2016Elisha W FinneyCFOSell9,000$96.95$872,550.00View SEC Filing  
9/6/2016Dow R WilsonInsiderSell10,000$96.08$960,800.00View SEC Filing  
9/1/2016Elisha W FinneyCFOSell2,000$95.82$191,640.00View SEC Filing  
8/5/2016Dow R WilsonInsiderSell10,000$95.14$951,400.00View SEC Filing  
8/1/2016Clarence R VerhoefSVPSell9,483$94.88$899,747.04View SEC Filing  
8/1/2016Elisha W FinneyCFOSell25,334$94.90$2,404,196.60View SEC Filing  
8/1/2016Timothy E. GuertinDirectorSell4,000$94.88$379,520.00View SEC Filing  
7/5/2016Dow R WilsonCEOSell10,000$82.08$820,800.00View SEC Filing  
6/27/2016Dow R WilsonCEOSell10,000$78.27$782,700.00View SEC Filing  
6/8/2016Ruediger Naumann-EtienneDirectorSell1,000$84.83$84,830.00View SEC Filing  
6/3/2016Mark R LaretDirectorSell1,545$83.48$128,976.60View SEC Filing  
5/2/2016Timothy E. GuertinDirectorSell4,000$81.55$326,200.00View SEC Filing  
4/20/2016Elisha W FinneyCFOSell4,000$85.95$343,800.00View SEC Filing  
4/18/2016Clarence R VerhoefSVPSell2,500$85.00$212,500.00View SEC Filing  
3/23/2016Dow R WilsonCEOSell45,650$78.86$3,599,959.00View SEC Filing  
3/10/2016Ruediger Naumann-EtienneDirectorSell428$77.99$33,379.72View SEC Filing  
3/7/2016Timothy E. GuertinDirectorSell4,000$79.47$317,880.00View SEC Filing  
2/17/2016Elisha W. FinneyCFOSell2,454$78.59$192,859.86View SEC Filing  
12/7/2015Dow R. WilsonCEOSell9,000$80.00$720,000.00View SEC Filing  
12/2/2015R Andrew EckertDirectorSell3,000$81.67$245,010.00View SEC Filing  
11/24/2015Elisha W. FinneyCFOSell2,334$80.90$188,820.60View SEC Filing  
11/6/2015Dow R. WilsonCEOSell18,000$80.26$1,444,680.00View SEC Filing  
9/8/2015Dow R. WilsonCEOSell9,000$80.05$720,450.00View SEC Filing  
7/6/2015Dow R WilsonCEOSell9,000$85.80$772,200.00View SEC Filing  
7/2/2015Elisha W FinneyCFOSell2,000$85.95$171,900.00View SEC Filing  
7/1/2015Timothy E GuertinDirectorSell25,000$84.20$2,105,000.00View SEC Filing  
6/5/2015Dow R WilsonCEOSell9,000$86.29$776,610.00View SEC Filing  
6/1/2015Elisha W FinneyCFOSell2,000$85.99$171,980.00View SEC Filing  
6/1/2015Timothy E GuertinDirectorSell25,000$86.08$2,152,000.00View SEC Filing  
5/6/2015Dow R WilsonCEOSell9,000$86.64$779,760.00View SEC Filing  
4/17/2015Dow R WilsonCEOSell18,760$93.63$1,756,498.80View SEC Filing  
4/1/2015Elisha W FinneyCFOSell5,000$92.76$463,800.00View SEC Filing  
4/1/2015Timothy E GuertinDirectorSell25,000$92.76$2,319,000.00View SEC Filing  
3/20/2015Dow R WilsonCEOSell18,759$94.44$1,771,599.96View SEC Filing  
3/16/2015Kolleen T KennedyEVPSell1,972$95.00$187,340.00View SEC Filing  
3/6/2015Timothy E GuertinDirectorSell4,000$93.50$374,000.00View SEC Filing  
3/2/2015Elisha W FinneyCFOSell5,000$93.44$467,200.00View SEC Filing  
3/2/2015Timothy E GuertinDirectorSell50,000$93.48$4,674,000.00View SEC Filing  
2/23/2015Elisha W FinneyCFOSell1,326$92.97$123,278.22View SEC Filing  
2/10/2015Mark R LaretDirectorSell10,000$92.32$923,200.00View SEC Filing  
2/3/2015Venkatraman ThyagarajanDirectorSell10,000$92.71$927,100.00View SEC Filing  
2/2/2015Dow R WilsonCEOSell60,000$91.78$5,506,800.00View SEC Filing  
2/2/2015Elisha W FinneyCFOSell6,667$91.79$611,963.93View SEC Filing  
2/2/2015John W KuoSVPSell3,490$92.04$321,219.60View SEC Filing  
2/2/2015Ruediger Naumann-EtienneDirectorSell10,000$91.87$918,700.00View SEC Filing  
1/5/2015Timothy E GuertinDirectorSell50,000$86.27$4,313,500.00View SEC Filing  
1/2/2015Elisha W FinneyCFOSell15,000$87.05$1,305,750.00View SEC Filing  
12/11/2014Timothy E GuertinDirectorSell105,000$86.67$9,100,350.00View SEC Filing  
12/1/2014Elisha W FinneyCFOSell21,000$88.72$1,863,120.00View SEC Filing  
11/24/2014Elisha W FinneyCFOSell2,930$88.24$258,543.20View SEC Filing  
11/17/2014Elisha W FinneyCFOSell1,837$87.71$161,123.27View SEC Filing  
11/11/2014Kolleen T KennedySVPSell1,242$85.79$106,551.18View SEC Filing  
11/10/2014Ruediger Naumann-EtienneDirectorSell5,000$85.31$426,550.00View SEC Filing  
11/3/2014Elisha W FinneyCFOSell25,000$83.82$2,095,500.00View SEC Filing  
11/3/2014Timothy E GuertinDirectorSell80,000$83.72$6,697,600.00View SEC Filing  
10/29/2014Elisha W FinneyCFOSell10,000$83.95$839,500.00View SEC Filing  
10/27/2014Kolleen T KennedySVPSell1,240$81.00$100,440.00View SEC Filing  
10/1/2014Elisha W FinneyCFOSell15,000$79.98$1,199,700.00View SEC Filing  
9/11/2014John W KuoSVPSell605$85.82$51,921.10View SEC Filing  
9/2/2014Elisha W FinneyCFOSell20,000$85.18$1,703,600.00View SEC Filing  
8/20/2014Venkatraman ThyagarajanDirectorSell5,000$84.25$421,250.00View SEC Filing  
8/7/2014Elisha W FinneyCFOSell5,000$83.95$419,750.00View SEC Filing  
8/1/2014Elisha W FinneyCFOSell15,000$81.66$1,224,900.00View SEC Filing  
8/1/2014Timothy E GuertinDirectorSell80,000$81.69$6,535,200.00View SEC Filing  
7/9/2014John W KuoSVPSell582$85.00$49,470.00View SEC Filing  
7/1/2014Elisha W FinneyCFOSell20,000$83.86$1,677,200.00View SEC Filing  
6/23/2014John W KuoSVPSell1,745$85.00$148,325.00View SEC Filing  
6/16/2014Kolleen T KennedySVPSell1,416$82.42$116,706.72View SEC Filing  
6/2/2014Elisha W FinneyCFOSell10,000$82.35$823,500.00View SEC Filing  
5/12/2014Kolleen KennedySVPSell1,417$81.96$116,137.32View SEC Filing  
5/1/2014Elisha FinneyCFOSell10,000$78.99$789,900.00View SEC Filing  
5/1/2014Timothy GuertinDirectorSell80,000$78.98$6,318,400.00View SEC Filing  
4/11/2014Kolleen T KennedySVPSell640$72.15$46,176.00View SEC Filing  
4/1/2014Elisha FinneyCFOSell10,000$83.97$839,700.00View SEC Filing  
3/17/2014Clarence VerhoefSVPSell1,140$84.70$96,558.00View SEC Filing  
3/11/2014Kolleen KennedySVPSell1,417$84.39$119,580.63View SEC Filing  
3/10/2014Timothy GuertinDirectorSell80,000$84.05$6,724,000.00View SEC Filing  
3/3/2014Elisha FinneyCFOSell10,000$83.41$834,100.00View SEC Filing  
2/21/2014Mark LaretDirectorSell1,411$84.06$118,608.66View SEC Filing  
2/11/2014Kolleen KennedySVPSell1,416$80.59$114,115.44View SEC Filing  
2/10/2014R Andrew EckertDirectorSell5,887$80.52$474,021.24View SEC Filing  
2/3/2014Elisha FinneyCFOSell10,000$79.34$793,400.00View SEC Filing  
2/3/2014Timothy GuertinDirectorSell27,000$79.34$2,142,180.00View SEC Filing  
1/31/2014Susan BostromDirectorSell18,900$81.50$1,540,350.00View SEC Filing  
1/2/2014Elisha FinneyCFOSell24,321$77.69$1,889,498.49View SEC Filing  
1/2/2014Richard LevyDirectorSell20,000$77.68$1,553,600.00View SEC Filing  
12/30/2013John KuoSVPSell3,027$77.08$233,321.16View SEC Filing  
12/23/2013Clarence VerhoefSVPSell1,297$76.13$98,740.61View SEC Filing  
12/9/2013Dow WilsonCEOSell95,000$79.09$7,513,550.00View SEC Filing  
12/4/2013Robert KlugeSVPSell12,932$80.00$1,034,560.00View SEC Filing  
12/2/2013Elisha FinneyCFOSell10,000$79.04$790,400.00View SEC Filing  
12/2/2013Richard LevyDirectorSell20,000$79.04$1,580,800.00View SEC Filing  
12/2/2013Robert KlugeSVPSell9,889$79.00$781,231.00View SEC Filing  
11/29/2013Kolleen KennedySVPSell9,307$78.00$725,946.00View SEC Filing  
11/25/2013Kolleen KennedySVPSell2,972$75.49$224,356.28View SEC Filing  
11/22/2013Elisha FinneyCFOSell1,617$74.83$121,000.11View SEC Filing  
11/14/2013Elisha FinneyCFOSell5,000$74.95$374,750.00View SEC Filing  
11/1/2013Elisha W FinneyCFOSell5,000$72.27$361,350.00View SEC Filing  
11/1/2013Richard M LevyDirectorSell20,000$72.27$1,445,400.00View SEC Filing  
10/14/2013Robert KlugeSVPSell13,889$78.00$1,083,342.00View SEC Filing  
10/10/2013Robert KlugeSVPSell13,871$77.00$1,068,067.00View SEC Filing  
9/20/2013Kolleen KennedySVPSell1,247$76.00$94,772.00View SEC Filing  
9/16/2013Elisha FinneyCFOSell16,334$74.95$1,224,233.30View SEC Filing  
9/16/2013Kolleen KennedySVPSell2,562$75.00$192,150.00View SEC Filing  
9/11/2013Elisha W FinneyCFOSell23,666$74.95$1,773,766.70View SEC Filing  
9/3/2013Elisha FinneyCFOSell5,000$70.95$354,750.00View SEC Filing  
9/3/2013Richard LevyDirectorSell20,000$70.95$1,419,000.00View SEC Filing  
8/8/2013Kolleen KennedySVPSell2,400$73.50$176,400.00View SEC Filing  
8/1/2013Elisha W FinneyCFOSell5,000$72.81$364,050.00View SEC Filing  
8/1/2013R Andrew EckertDirectorSell1,375$72.93$100,278.75View SEC Filing  
7/19/2013John W KuoSVPSell1,817$72.00$130,824.00View SEC Filing  
7/17/2013Richard M LevyDirectorSell20,000$70.00$1,400,000.00View SEC Filing  
7/16/2013Elisha W FinneyCFOSell5,000$69.95$349,750.00View SEC Filing  
6/17/2013Elisha W FinneyCFOSell5,000$69.95$349,750.00View SEC Filing  
6/17/2013Richard M LevyDirectorSell20,000$70.00$1,400,000.00View SEC Filing  
6/10/2013Timothy E GuertinDirectorSell27,000$68.81$1,857,870.00View SEC Filing  
5/21/2013Elisha W FinneyCFOSell2,313$69.86$161,586.18View SEC Filing  
5/14/2013Elisha W FinneyCFOSell5,000$69.95$349,750.00View SEC Filing  
5/14/2013John W KuoSVPSell1,112$70.00$77,840.00View SEC Filing  
5/14/2013Richard M LevyDirectorSell20,000$70.00$1,400,000.00View SEC Filing  
2/14/2013John W KuoSVPSell1,111$71.05$78,936.55View SEC Filing  
9/4/2012Kolleen T KennedySVPSell1,900$64.00$121,600.00View SEC Filing  
8/20/2012Elisha W FinneyCFOSell4,000$59.95$239,800.00View SEC Filing  
(Data available from 1/1/2013 forward)


Headline Trends for Varian Medical Systems (NYSE:VAR)
Latest Headlines for Varian Medical Systems (NYSE:VAR)
DateHeadline logoInsider Selling: Varian Medical Systems, Inc. (VAR) EVP Sells 931 Shares of Stock - October 19 at 10:32 PM logoUZ Leuven Treats First Patient in Europe on Varian Halcyon Cancer Treatment System - October 17 at 8:43 AM logoVarian Medical Systems, Inc. (VAR) Scheduled to Post Quarterly Earnings on Tuesday - October 17 at 4:12 AM logoKolleen T. Kennedy Sells 1,088 Shares of Varian Medical Systems, Inc. (VAR) Stock - October 13 at 4:20 PM logoVarian Medical Systems, Inc. – Value Analysis (NYSE:VAR) : October 11, 2017 - October 11 at 4:33 PM logoVarian Medical Systems, Inc. breached its 50 day moving average in a Bearish Manner : VAR-US : October 10, 2017 - October 11 at 9:11 AM logoVarian Medical Systems, Inc. (VAR) Director R Andrew Eckert Sells 5,651 Shares - October 6 at 10:34 PM logoVarian Medical Systems, Inc. (VAR) Insider Sells $1,542,041.60 in Stock - October 6 at 10:34 PM logoVarian Medical Systems, Inc. (VAR) Expected to Post Quarterly Sales of $741.71 Million - October 4 at 8:58 AM logoMarket Research on NMR Spectrometer in China 2017-2022 - Research and Markets - October 3 at 2:26 PM logoMarket Research on NMR Spectrometer in China 2017-2022 - Research and Markets - October 3 at 2:26 PM logoVarian Publishes 2017 Sustainability Report - October 3 at 2:26 PM logoVarian Publishes 2017 Sustainability Report - October 3 at 2:26 PM logoVarian Medical Systems, Inc. (VAR) Receives Average Recommendation of "Hold" from Analysts - October 1 at 8:50 PM logoReviewing Varian Medical Systems (VAR) & GenMark Diagnostics (GNMK) - September 29 at 2:30 AM logoVarian Announces Penn Medicine Treats World's First Patient on Halcyon System - September 23 at 10:38 AM logoForm 4/A VARIAN MEDICAL SYSTEMS For: Sep 12 Filed by: KENNEDY KOLLEEN T - September 20 at 10:49 AM logoVarian Ranks First in Overall Manufacturer, System, and Service Performance in 2017 Survey of Radiation Oncology Professionals - September 20 at 10:49 AM logoVarian Medical (VAR) Releases FDA-Approved Eclipse 15.5 - September 19 at 9:15 AM logoVarian Expands Clinicians' Cancer-fighting Toolkit with Eclipse 15.5 - September 19 at 9:15 AM logoVarian to Showcase Latest Technologies and Software for Advanced Cancer Care at ASTRO 2017 - September 19 at 9:15 AM logoVarian Conducts Clinical Workshop, Strengthens Algeria Hold - September 18 at 7:45 AM logoNotable Friday Option Activity: VAR, GD, DAR - Nasdaq - September 15 at 3:41 PM logoVarian Holds First Clinical Workshop at New Algeria Facility - September 15 at 11:00 AM logoInsider Selling: Varian Medical Systems, Inc. (VAR) EVP Sells 933 Shares of Stock - September 14 at 4:32 PM logoVarian Medical Systems, Inc. (VAR) Expected to Post Earnings of $1.19 Per Share - September 14 at 6:28 AM logoForm 4 VARIAN MEDICAL SYSTEMS For: Sep 12 Filed by: KENNEDY KOLLEEN T - September 14 at 1:26 AM logoCONMED Corporation (CNMD) Ex-Dividend Date Scheduled for September 14, 2017 - Nasdaq - September 13 at 8:23 PM logoVarian Medical Systems, Inc. (VAR) EVP Kolleen T. Kennedy Sells 1,088 Shares - September 13 at 4:34 PM logoVarian Medical Systems, Inc. (VAR) Downgraded by BTIG Research - September 10 at 8:24 AM logoDow R. Wilson Sells 15,059 Shares of Varian Medical Systems, Inc. (VAR) Stock - September 8 at 4:22 PM logoBenzinga's Top Upgrades, Downgrades For September 7, 2017 - Benzinga - September 7 at 10:45 AM logoVarian Medical Systems, Inc. (VAR) Receives Consensus Rating of "Hold" from Analysts - September 6 at 10:58 PM logoVarian Medical Systems, Inc. (VAR) Rating Reiterated by Royal Bank Of Canada - September 2 at 7:34 AM logoContrasting Varian Medical Systems (VAR) & Hologic (HOLX) - September 1 at 10:12 PM logoVarian Medical Systems, Inc. (VAR) Rating Reiterated by Robert W. Baird - August 28 at 12:00 PM logoVarian Medical Systems Announces Fiscal Year 2017 Fourth Quarter Earnings Release Date and Upcoming Investor ... - PR Newswire (press release) - August 26 at 5:24 AM logoVarian Medical Systems Announces Fiscal Year 2017 Fourth Quarter Earnings Release Date and Upcoming Investor Events - August 25 at 12:14 PM logoETFs with exposure to Varian Medical Systems, Inc. : August 21, 2017 - August 23 at 1:25 PM logoVarian Medical Systems, Inc. breached its 50 day moving average in a Bullish Manner : VAR-US : August 23, 2017 - August 23 at 1:25 PM logoVarian Medical Systems’ Recent Stock Performance - August 17 at 9:00 AM logoHead-To-Head Contrast: Varian Medical Systems (VAR) versus ABIOMED (ABMD) - August 17 at 4:50 AM logoVarian’s Oncology Business Grows in Emerging Markets - August 15 at 3:35 PM logoVarian’s Halcyon Treatment System Sees Emerging Market Demand - August 15 at 3:35 PM logoVarian Medical Systems to Hold Investor Meeting at ASTRO in San Diego - August 15 at 7:59 AM logoWhy Varian Medical Systems’ Profitability Is Improving - August 15 at 7:59 AM logoPro-Trader Daily: Corporate News Blog - Bionix(R) Radiation Therapy Signs on Varian Medical Systems as Distributor for its Brachytherapy Applicators - August 11 at 8:47 PM logoSee what the IHS Markit Score report has to say about Varian Medical Systems Inc. - August 11 at 3:43 PM logoVarian Announces New VP of Investor Relations - PR Newswire (press release) - August 10 at 8:35 PM logoVarian Medical (VAR) Signs Distribution Deal with Bionix - Nasdaq - August 10 at 8:35 PM



Varian Medical Systems (VAR) Chart for Friday, October, 20, 2017

This page was last updated on 10/20/2017 by Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.